Found 241 results
[ Author(Asc)] Keyword Title Type Year
Filters: First Letter Of Keyword is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Lytle KA, Jump DB.  2016.  Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible? PLoS One. 11(1):e0146942.
Lytle KA, Wong CP, Jump DB.  2017.  Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.. PLoS One. 12(4):e0173376.
Loza AMárquez, Elias V, Wong CP, Ho E, Bermudez M, Magnusson KR.  2017.  Effects of ibuprofen on cognition and NMDA receptor subunit expression across aging.. Neuroscience. 344:276-292.
Lowry MB, Guo C, Zhang Y, Fantacone ML, Logan IE, Campbell Y, Zhang W, Le M, Indra AK, Ganguli-Indra G et al..  2020.  A mouse model for vitamin D-induced human cathelicidin antimicrobial peptide gene expression.. J Steroid Biochem Mol Biol. 198:105552.
Li Q, Löhr CV, Dashwood RH.  2009.  Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse.. Cancer Lett. 283(1):36-42.
Li Q, Löhr CV, Dashwood RH.  2009.  Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse.. Cancer Lett. 283(1):36-42.
Li L, Frei B.  2006.  Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity.. Arterioscler Thromb Vasc Biol. 26(12):2638-43.
Li Q, Löhr CV, Dashwood RH.  2009.  Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse.. Cancer Lett. 283(1):36-42.
Li Q, Dixon BM, Al-Fageeh M, Blum CA, Dashwood RH.  2002.  Sequencing of the rat beta-catenin gene (Ctnnb1) and mutational analysis of liver tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline.. Gene. 283(1-2):255-62.
Li L, Frei B.  2009.  Prolonged exposure to LPS increases iron, heme, and p22phox levels and NADPH oxidase activity in human aortic endothelial cells: inhibition by desferrioxamine.. Arterioscler Thromb Vasc Biol. 29(5):732-8.
Li L, Smith A, Hagen TM, Frei B.  2010.  Vascular oxidative stress and inflammation increase with age: ameliorating effects of alpha-lipoic acid supplementation.. Ann N Y Acad Sci. 1203:151-9.
Leung PY, Dunham WB, Tsao CS.  1992.  Ascorbic acid with cupric ions as a chemotherapy for human lung tumor xenografts implanted beneath the renal capsule of immunocompetent mice.. In Vivo. 6(1):33-40.
Leung PY, Tsao CS.  1992.  Preparation of an optimum mobile phase for the simultaneous determination of neurochemicals in mouse brain tissues by high-performance liquid chromatography with electrochemical detection.. J Chromatogr. 576(2):245-54.
Leonard SW, Bruno RS, Paterson E, Schock BC, Atkinson J, Bray TM, Cross CE, Traber MG.  2003.  5-nitro-gamma-tocopherol increases in human plasma exposed to cigarette smoke in vitro and in vivo.. Free Radic Biol Med. 35(12):1560-7.
Leinweber B, Barofsky E, Barofsky DF, Ermilov V, Nylin K, Beckman JS.  2004.  Aggregation of ALS mutant superoxide dismutase expressed in Escherichia coli.. Free Radic Biol Med. 36(7):911-8.
Legette LC, Ma L, Reed RL, Miranda CL, Christensen JMark, Rodriguez-Proteau R, Stevens JF.  2012.  Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration.. Mol Nutr Food Res. 56(3):466-74.
Lebold KM, Grant KA, Freeman WM, Wiren KM, Miller GW, Kiley C, Leonard SW, Traber MG.  2011.  Individual differences in hyperlipidemia and vitamin E status in response to chronic alcohol self-administration in cynomolgus monkeys.. Alcohol Clin Exp Res. 35(3):474-83.
LaVere AM, Marcroft KR, Smith RC, Sarka RJ.  1994.  Denture tooth selection: size matching of natural anterior tooth width with artificial denture teeth.. J Prosthet Dent. 72(4):381-4.
Larsen CA, Dashwood RH.  2010.  (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells.. Arch Biochem Biophys. 501(1):52-7.
Langley BO, Ryan JJoan, Phipps J, Buttolph L, Bray B, Aslan JE, Metz TO, Stevens JF, Bradley R.  2022.  Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.. Trials. 23(1):885.

Pages